S&P 500   3,790.93 (+3.06%)
DOW   30,316.32 (+2.80%)
QQQ   282.26 (+3.19%)
AAPL   145.91 (+2.43%)
MSFT   248.82 (+3.36%)
META   140.28 (+1.20%)
GOOGL   101.61 (+3.01%)
AMZN   121.08 (+4.49%)
TSLA   248.93 (+2.69%)
NVDA   131.70 (+5.26%)
NIO   16.70 (+7.81%)
BABA   84.13 (+4.57%)
AMD   67.84 (+2.62%)
T   16.08 (+1.13%)
MU   53.97 (+4.35%)
CGC   3.13 (+7.56%)
F   12.31 (+7.32%)
GE   67.54 (+6.19%)
DIS   101.46 (+4.46%)
AMC   7.75 (+12.65%)
PYPL   92.82 (+6.47%)
PFE   44.46 (+0.72%)
NFLX   240.88 (+0.77%)
S&P 500   3,790.93 (+3.06%)
DOW   30,316.32 (+2.80%)
QQQ   282.26 (+3.19%)
AAPL   145.91 (+2.43%)
MSFT   248.82 (+3.36%)
META   140.28 (+1.20%)
GOOGL   101.61 (+3.01%)
AMZN   121.08 (+4.49%)
TSLA   248.93 (+2.69%)
NVDA   131.70 (+5.26%)
NIO   16.70 (+7.81%)
BABA   84.13 (+4.57%)
AMD   67.84 (+2.62%)
T   16.08 (+1.13%)
MU   53.97 (+4.35%)
CGC   3.13 (+7.56%)
F   12.31 (+7.32%)
GE   67.54 (+6.19%)
DIS   101.46 (+4.46%)
AMC   7.75 (+12.65%)
PYPL   92.82 (+6.47%)
PFE   44.46 (+0.72%)
NFLX   240.88 (+0.77%)
S&P 500   3,790.93 (+3.06%)
DOW   30,316.32 (+2.80%)
QQQ   282.26 (+3.19%)
AAPL   145.91 (+2.43%)
MSFT   248.82 (+3.36%)
META   140.28 (+1.20%)
GOOGL   101.61 (+3.01%)
AMZN   121.08 (+4.49%)
TSLA   248.93 (+2.69%)
NVDA   131.70 (+5.26%)
NIO   16.70 (+7.81%)
BABA   84.13 (+4.57%)
AMD   67.84 (+2.62%)
T   16.08 (+1.13%)
MU   53.97 (+4.35%)
CGC   3.13 (+7.56%)
F   12.31 (+7.32%)
GE   67.54 (+6.19%)
DIS   101.46 (+4.46%)
AMC   7.75 (+12.65%)
PYPL   92.82 (+6.47%)
PFE   44.46 (+0.72%)
NFLX   240.88 (+0.77%)
S&P 500   3,790.93 (+3.06%)
DOW   30,316.32 (+2.80%)
QQQ   282.26 (+3.19%)
AAPL   145.91 (+2.43%)
MSFT   248.82 (+3.36%)
META   140.28 (+1.20%)
GOOGL   101.61 (+3.01%)
AMZN   121.08 (+4.49%)
TSLA   248.93 (+2.69%)
NVDA   131.70 (+5.26%)
NIO   16.70 (+7.81%)
BABA   84.13 (+4.57%)
AMD   67.84 (+2.62%)
T   16.08 (+1.13%)
MU   53.97 (+4.35%)
CGC   3.13 (+7.56%)
F   12.31 (+7.32%)
GE   67.54 (+6.19%)
DIS   101.46 (+4.46%)
AMC   7.75 (+12.65%)
PYPL   92.82 (+6.47%)
PFE   44.46 (+0.72%)
NFLX   240.88 (+0.77%)
NASDAQ:QTRX

Quanterix - QTRX Stock Forecast, Price & News

$11.46
+0.98 (+9.35%)
(As of 10/4/2022 03:59 PM ET)
Add
Compare
Today's Range
$10.72
$11.91
50-Day Range
$7.46
$17.47
52-Week Range
$6.31
$60.92
Volume
25,080 shs
Average Volume
710,681 shs
Market Capitalization
$423.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.33

Quanterix MarketRank™ Forecast

Analyst Rating
Hold
2.14 Rating Score
Upside/​Downside
128.6% Upside
$26.33 Price Target
Short Interest
Healthy
2.77% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.59mentions of Quanterix in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
$2.70 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.98) to ($1.43) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.56 out of 5 stars

Medical Sector

154th out of 1,087 stocks

Analytical Instruments Industry

9th out of 29 stocks

QTRX stock logo

About Quanterix (NASDAQ:QTRX) Stock

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Receive QTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

QTRX Stock News Headlines

Quanterix Corporation: Selling For Less Than Cash Value
Quanterix Corporation (QTRX)
Why Quanterix Shares Plunged by Nearly 55% Today
See More Headlines
Receive QTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

QTRX Company Calendar

Last Earnings
8/08/2022
Today
10/04/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:QTRX
Fax
N/A
Employees
460
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$26.33
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+129.8%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
7 Analysts

Profitability

Net Income
$-57,690,000.00
Pretax Margin
-71.01%

Debt

Sales & Book Value

Annual Sales
$110.56 million
Book Value
$12.03 per share

Miscellaneous

Free Float
33,955,000
Market Cap
$423.91 million
Optionable
Not Optionable
Beta
1.36

Key Executives

  • Masoud Toloue
    President, Chief Executive Officer & Director
  • Gerrit Smith
    Senior Vice President-Operations
  • Michael A. Doyle
    Chief Financial Officer
  • David C. DuffyDavid C. Duffy
    Chief Technology Officer & Vice President-Research
  • Richard Haigh
    Senior Vice President-Research Products













QTRX Stock - Frequently Asked Questions

Should I buy or sell Quanterix stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last year. There are currently 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" QTRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QTRX, but not buy additional shares or sell existing shares.
View QTRX analyst ratings
or view top-rated stocks.

What is Quanterix's stock price forecast for 2022?

7 Wall Street research analysts have issued twelve-month target prices for Quanterix's shares. Their QTRX share price forecasts range from $12.00 to $60.00. On average, they expect the company's share price to reach $26.33 in the next twelve months. This suggests a possible upside of 128.0% from the stock's current price.
View analysts price targets for QTRX
or view top-rated stocks among Wall Street analysts.

How have QTRX shares performed in 2022?

Quanterix's stock was trading at $42.40 at the beginning of 2022. Since then, QTRX stock has decreased by 72.8% and is now trading at $11.55.
View the best growth stocks for 2022 here
.

When is Quanterix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our QTRX earnings forecast
.

How were Quanterix's earnings last quarter?

Quanterix Co. (NASDAQ:QTRX) issued its earnings results on Monday, August, 8th. The company reported ($0.67) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.67). The firm had revenue of $23.50 million for the quarter, compared to the consensus estimate of $29.54 million. Quanterix had a negative net margin of 70.92% and a negative trailing twelve-month return on equity of 18.22%.

What is Kevin Hrusovsky's approval rating as Quanterix's CEO?

15 employees have rated Quanterix Chief Executive Officer Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among the company's employees.

What other stocks do shareholders of Quanterix own?
When did Quanterix IPO?

(QTRX) raised $50 million in an IPO on Thursday, December 7th 2017. The company issued 3,300,000 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners acted as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

How do I buy shares of Quanterix?

Shares of QTRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $11.55.

How much money does Quanterix make?

Quanterix (NASDAQ:QTRX) has a market capitalization of $427.23 million and generates $110.56 million in revenue each year. The company earns $-57,690,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis.

How many employees does Quanterix have?

The company employs 460 workers across the globe.

How can I contact Quanterix?

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The official website for the company is www.quanterix.com. The company can be reached via phone at (617) 301-9400 or via email at ir@quanterix.com.

This page (NASDAQ:QTRX) was last updated on 10/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.